Role of size and surface area for pro-inflammatory responses to silica nanoparticles in epithelial lung cells: importance of exposure conditions.

[1]  M. Lag,et al.  Importance of agglomeration state and exposure conditions for uptake and pro-inflammatory responses to amorphous silica nanoparticles in bronchial epithelial cells , 2012, Nanotoxicology.

[2]  M. Lag,et al.  Comparison of non-crystalline silica nanoparticles in IL-1β release from macrophages , 2012, Particle and Fibre Toxicology.

[3]  Benoit Nemery,et al.  Cytokine production by co-cultures exposed to monodisperse amorphous silica nanoparticles: the role of size and surface area. , 2012, Toxicology letters.

[4]  Jeremy L. Steinbacher,et al.  Differences in gene expression and cytokine production by crystalline vs. amorphous silica in human lung epithelial cells , 2012, Particle and Fibre Toxicology.

[5]  François Huaux,et al.  Influence of size, surface area and microporosity on the in vitro cytotoxic activity of amorphous silica nanoparticles in different cell types , 2010, Nanotoxicology.

[6]  Moonjung Choi,et al.  Cellular uptake, cytotoxicity, and innate immune response of silica-titania hollow nanoparticles based on size and surface functionality. , 2010, ACS nano.

[7]  Marianne Geiser,et al.  Update on macrophage clearance of inhaled micro- and nanoparticles. , 2010, Journal of aerosol medicine and pulmonary drug delivery.

[8]  E. Antignac,et al.  Safety assessment of personal care products/cosmetics and their ingredients. , 2010, Toxicology and applied pharmacology.

[9]  Jinhee Choi,et al.  Oxidative stress of silica nanoparticles in human bronchial epithelial cell, Beas-2B. , 2009, Toxicology in vitro : an international journal published in association with BIBRA.

[10]  David B Warheit,et al.  A role for nanoparticle surface reactivity in facilitating pulmonary toxicity and development of a base set of hazard assays as a component of nanoparticle risk management , 2009, Inhalation toxicology.

[11]  P. Couvreur,et al.  Nanocarriers’ entry into the cell: relevance to drug delivery , 2009, Cellular and Molecular Life Sciences.

[12]  Laetitia Gonzalez,et al.  Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. , 2009, Small.

[13]  James L. McGrath,et al.  The influence of protein adsorption on nanoparticle association with cultured endothelial cells. , 2009, Biomaterials.

[14]  J. Pounds,et al.  Macrophage responses to silica nanoparticles are highly conserved across particle sizes. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[15]  V. Castranova,et al.  Pulmonary response to intratracheal instillation of ultrafine versus fine titanium dioxide: role of particle surface area , 2008, Particle and Fibre Toxicology.

[16]  Conrad Coester,et al.  Particle and Fibre Toxicology BioMed Central Methodology , 2008 .

[17]  Kenneth A. Dawson,et al.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.

[18]  Laetitia Gonzalez,et al.  Nominal and effective dosimetry of silica nanoparticles in cytotoxicity assays. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[19]  J. Veranth,et al.  Effects of cell type and culture media on Interleukin-6 secretion in response to environmental particles. , 2008, Toxicology in vitro : an international journal published in association with BIBRA.

[20]  P. Borm,et al.  Endocytosis, oxidative stress and IL-8 expression in human lung epithelial cells upon treatment with fine and ultrafine TiO2: role of the specific surface area and of surface methylation of the particles. , 2007, Toxicology and applied pharmacology.

[21]  E. Oberdörster,et al.  Concepts of Nanoparticle Dose Metric and Response Metric , 2007, Environmental health perspectives.

[22]  W. MacNee,et al.  The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area , 2007, Occupational and Environmental Medicine.

[23]  Joel G Pounds,et al.  Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[24]  David M. Brown,et al.  Proinflammogenic Effects of Low-Toxicity and Metal Nanoparticles In Vivo and In Vitro: Highlighting the Role of Particle Surface Area and Surface Reactivity , 2007, Inhalation toxicology.

[25]  Xiao-Dong Zhou,et al.  In vitro toxicity of silica nanoparticles in human lung cancer cells. , 2006, Toxicology and applied pharmacology.

[26]  Julie W. Fitzpatrick,et al.  Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy , 2005, Particle and Fibre Toxicology.

[27]  J. Heyder,et al.  Instillation of Six Different Ultrafine Carbon Particles Indicates a Surface Area Threshold Dose for Acute Lung Inflammation in Mice , 2005, Environmental health perspectives.

[28]  A. C. Hunter,et al.  Nanomedicine: current status and future prospects , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  Paul R. Lockman,et al.  Nanoparticle Surface Charges Alter Blood–Brain Barrier Integrity and Permeability , 2004, Journal of drug targeting.

[30]  B. Veronesi,et al.  The surface charge of visible particulate matter predicts biological activation in human bronchial epithelial cells. , 2002, Toxicology and applied pharmacology.

[31]  David M. Brown,et al.  Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. , 2001, Toxicology and applied pharmacology.

[32]  M. Refsnes,et al.  Silica-induced cytokine release from A549 cells: importance of surface area versus size , 2001, Human & experimental toxicology.

[33]  John Meurig Thomas.  Principles and practice of heterogeneous catalysis , 1996 .

[34]  B. Lehnert,et al.  Correlation Between Particle Size, in Vivo Particle Persistence, and Lung Injury , 1994 .

[35]  David B Warheit,et al.  Pulmonary bioassay studies with nanoscale and fine-quartz particles in rats: toxicity is not dependent upon particle size but on surface characteristics. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[36]  K. Donaldson,et al.  Inhalation of poorly soluble particles. II. Influence Of particle surface area on inflammation and clearance. , 2000, Inhalation toxicology.

[37]  François Huaux,et al.  Influence of particle surface area on the toxicity of insoluble manganese dioxide dusts , 1997, Archives of Toxicology.